Stem Cell

The heart muscle cells and connective tissue cells were generated from induced pluripotent stem cells. (Image: Nathaniel Huebsch, PhD)

Stem cells form tiny beating heart for drug testing

By Melissa Fassbender

While there are currently several techniques for producing tissue from heart cells, a new method reduces the amount of cells needed, making it easier and cheaper to replicate.

Best before... Image: StanleyD

Cell Therapy Manufacturing & Gene Therapy Congress - Brussels, Belgium

Short shelf-life poses problems for cell therapy makers, Chiesi

By Dan Stanton

The shelf life of a cell therapy product is crucial in determining a firm’s manufacturing strategy according to the makers of the first approved stem-cell based drug.

The “mini-brains” are 350 micrometers in diameter. (Image: iStock)

'Mini-brains' to improve drug testing

By Melissa Fassbender

Researchers at the Johns Hopkins have developed "mini-brains" made up of human brain cells and neurons which can be reproduced in mass quantities.

Japan’s PuRec to supply mesenchymal stem cells

Japan’s PuRec to supply mesenchymal stem cells

By Wang Fangqing

Regenerative medicine developers now have a new supplier for mesenchymal stem cells (MSCs), the multipotent stromal cells derived from marrow and other tissues like muscle and dental pulp for tissue repair.

apceth expands gene, cell therapy manufacturing business

apceth expands gene, cell therapy manufacturing business

By Zachary Brennan

German-based contract manufacturer apceth has received regulatory approval to use two new GMP cleanrooms for aseptic processing, which will be used for the handling and genetic manipulation of various types of cell and gene therapies. 

UK scientists announce breakthrough in stem cell manufacturing

UK scientists announce breakthrough in stem cell manufacturing

By Zachary Brennan

Scientists at the University of Nottingham have created a new combination of hydrogels that allows dense tissue structures to be produced from human pluripotent stem cells (HPSC) in a single step process never achieved before.

Temple of the Golden Pavilion, Kyoto, Japan

Catalent moves into Japan to manufacture regenerative therapy

By Zachary Brennan

Catalent Pharma Solutions has agreed with the Center for iPS Cell Research and Application (CiRA) at Kyoto University in Japan to advance one of the first regenerative human therapies with induced pluripotent stem (iPS) cells applicable to humans. 

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers